HAI Pathogens and Antimicrobial Resistance Report, 2018-2021

Data Tables - Adult HAIs

Print
Related Pages

The tables below summarize NHSN HAI pathogen data from adult patients from 2018-2021; over 400,000 pathogens were reported by almost 5,000 healthcare facilities. Common pathogens varied by HAI and facility type. Overall percentages of antimicrobial resistance (AR) remain concerning for some phenotypes of public health importance; refer to Table 11 for summarized results on the 8 AR phenotypes included in this report.

On This Page
Facility Characteristics

Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN, Adults, 2018 – 2021

Pathogen Distributions

Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type, Adults, 2018-2021

Table 3. The Top 15 HAI Pathogens Reported to NHSN, Adults, 2018 – 2021

Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type, Adults, 2018-2021

Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type, Adults, 2018-2021

Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type, Adults, 2018-2021

Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type, Adults, 2018-2021

Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type, Adults, 2018-2021

Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume, Adults, 2018-2021

Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume, Adults, 2018-2021

Antimicrobial Resistance

Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type, Adults, 2018-2021

Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type, Adults, 2018-2021

Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status, Adults, 2018-2021

Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type, Adults, 2018-2021

Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type, Adults, 2018-2021

Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume, Adults, 2018-2021

Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume, Adults, 2018-2021

Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type, Adults, 2018-2021